What are the current challenges for machine learning in drug discovery and repurposing?

Expert Opin Drug Discov. 2022 May;17(5):423-425. doi: 10.1080/17460441.2022.2050694. Epub 2022 Mar 8.

Author

Tero Aittokallio^{1

2

3}

Affiliations

¹ Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
² Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.
³ Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, Norway.

PMID: 35255749
DOI: 10.1080/17460441.2022.2050694

No abstract available

Publication types

Editorial

MeSH terms

Drug Discovery
Drug Repositioning*
Humans
Machine Learning*